Description
The New Saridon Tablet is a combination medication specifically designed to manage mild to moderate forms of pain. It is effective for managing different headache types, migraines, backaches, rheumatic and muscle pain. Furthermore, it assists in relieving the discomfort associated with colds, influenza, and sore throats.
Medical Benefits
New Saridon for Fast Headache Relief Tablets is a combination medication containing paracetamol (acetaminophen) and caffeine. New Saridon for Fast Headache Relief Tablets effectively treats mild to moderate pain, including headache, backache, migraine, rheumatic and muscle pain, toothache and period pain. On the other hand, it also relieves discomfort in colds, influenza, and sore throats and helps reduce temperature. Paracetamol inhibits the release of these enzymes and alleviates pain. Caffeine increases the efficacy of paracetamol by improving its absorption, thereby prolonging analgesic action. Paracetamol also has an antipyretic effect and can reduce body temperature in cases of fever.
Direction for use
Swallow it as a whole with water; do not crush, break or chew it.
Side effects
Insomnia
Nervousness
Restlessness
Nausea
Increased Heart Rate
Agitation
Nervousness
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our ‘Platform’, we make no warranties or representations and disclaim all responsibility and liability for the content’s completeness, accuracy, or reliability. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user’s risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query about medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
In Stock
Reviews
There are no reviews yet.